Biphosphonates

Biphosphonates

Compounds (like alendronate) that slow bone loss and increase bone density.
Mentioned in: Osteoporosis
References in periodicals archive ?
1,5 Biphosphonates, phosphate binders, cinacalcet and sodium thiosulfate may be used.
The effectiveness of antiresorptive agents, such as biphosphonates and denosumab, can be limited due to intolerance, adverse events, and non-adherence.
Its annually parenteral route of administration maintains a high level of patient compliance and persistence with therapy which is particularly important in patients who do not adhere to or tolerate oral biphosphonates.
In order to acquire a reliable conclusion, we compiled all available data from a few prospective or randomized researches and carried out a meta-analysis to assess the efficacy of biphosphonates on the subsequent hip fracture in the elderly patients with hip fracture.
Biphosphonates (alendronate, etidronate, risedroante), is elective o estrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the primary prevention of osteoporotic fragility fractures in postmenopausal women.
Par ailleurs, d'autres produits alternatifs pour la prise en charge de certaines pathologies frequentes feront partie de cette septieme liste additive, il s'agit entre autres, des antithrombotiques, utilises dans le traitement et la prevention primaire et/ou secondaire dans diverses indications cardio-vasculaires, les antiviraux indiques dans le traitement de l'hepatite B, les biphosphonates indiques dans le traitement de l'osteoporose de l'osteopenie et de la maladie de Paget(affection chronique des os), ainsi que les antianemiques indiques dans le traitement de l'anemie d'origine renale .
Symptomatic treat ments include vagotomy, non-steroidal anti-inflammatory drugs (NSAIDs), steroids, biphosphonates (pamidronate and zoledronic acid), octreotide, epidermal growth factor receptor (EGFR) inhibitor and adrenergic antagonists.
Sodium thiosulfate and biphosphonates have demonstrated beneficial outcomes in the management of calciphylaxis (Raymond & Wazny, 2008).
Biphosphonates in the treatment of thalassemia-induced osteoporosis.
There are many different therapies including biphosphonates which can decrease loss of bone and decrease fracture risk in patients who already have had sustained a fracture.
Incorporation of bone antiresorptive drugs, such as biphosphonates, might be very relevant in clinical cases lacking bone support, e.